A prospective observational study of catheter-related bacteraemia and thrombosis in a haemodialysis cohort: Univariate and multivariate analyses of risk association

Nephrology Dialysis Transplantation

Volumn 25, Issue 5, 2010, Pages 1596-1604

  Thomson, Peter ^a   Stirling, Catherine ^a   Traynor, Jamie ^b   Morris, Scott ^a   MacTier, Robert ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b MONKLANDS HOSPITAL   (United Kingdom)

Author keywords

Bacteraemia; Catheter; Complications; Haemodialysis; Thrombosis

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; C REACTIVE PROTEIN; CALCIUM; HEMOGLOBIN; IMMUNOSUPPRESSIVE AGENT; PHOSPHATE; PREDNISOLONE; STATIN; UREA;

ACUTE KIDNEY FAILURE; ADULT; ADVERSE OUTCOME; AGE DISTRIBUTION; AGED; ARTICLE; BACTEREMIA; BLOOD FLOW; BLOOD PUMP; BODY MASS; CATHETER INFECTION; CATHETER REMOVAL; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; INTERNAL JUGULAR VEIN; LABORATORY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SEX RATIO; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; VASCULAR ACCESS;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; C-REACTIVE PROTEIN; CATHETER-RELATED INFECTIONS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK; THROMBOSIS;

EID: 77951688422     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp667     Document Type: Article

References (22)

1. NKF-KDOQI. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006; 48: 176-247
2. Schwab SJ, Harrington JT, Singh A, et al. Vascular access for hemo-dialysis. Kidney Int 1999; 55: 2078-2090
3. Schwab SJ, Beathard G. The hemodialysis catheter conundrum: hate living with them, but can't livewithout them. Kidney Int 1999; 56: 1-17 (Pubitemid 29300516)
4. Burr R, Marszalek J, Saul M, et al. The cost of vascular access infections: three years experience from a single out-patient dialysis center. Haemodial Int 2003; 7: 73-104
5. Liu JW, Su YK, Liu CF, et al. Nosocomial blood-stream infection in patients with end-stage renal disease: excess length of hospital stay, extra cost and attributable mortality. J Hosp Infect 2002; 50: 224-227
6. United States Renal Data System. 2007 Annual data report: hospi-talization & mortality; 2007 United States Renal Data System. 2007 Annual data report: causes of death 2007
7. UK Renal Association. Clinical practice guidelines 4th edition: hae-modialysis 2007
8. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383 (Pubitemid 17055592)
9. van Manen JG, Korevaar JC, Dekker FW, et al. NECOSAD Study Group. How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis 2002; 40: 82-89
10. Hemmelgarn BR, Manns BJ, Quan H, et al. Adapting the Charlson comorbidity index for use in patients with ESRD. Am J Kidney Dis 2003; 42: 125-132 (Pubitemid 36807661)
11. Thomson PC, Stirling CM, Geddes CC, et al. Vascular access in hae-modialysis patients: a modifiable risk factor for bacteraemia and death. QJM 2007; 100: 415-422
12. Weijmer MC, Vervloet MG, Wee PM. Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol Dial Transplant 2004; 19: 670-677
13. Klouche K, Amiques L, Deleuze S, et al. Complications, effects on dialysis dose, and survival of tunneled femoral dialysis catheters in acute renal failure. Am J Kidney Dis 2007; 49: 99-108 (Pubitemid 44918173)
14. Oliver MJ, Callery SM, Thorpe KE, et al. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int 2000; 58: 2543-2545
15. Parienti J, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy. JAMA 2008; 299: 2413-2422
16. Naumovic RT, Jovanovic DB, Djukanovic LJ. Temporary vascular catheters for hemodialysis: a 3-year prospective study. Int J Artif Organs 2004; 27: 848-854
17. Hryszko T, Brzosko S, Mazerska M, et al. Risk factors of non-tunnelled non-cuffed hemodialysis catheter malfunction. Nephron Clin Pract 2004; 96: 43-47 (Pubitemid 38456609)
18. Mendelssohn DC, Ethier J, Elder SJ, et al. Haemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrol Dial Transplant 2006; 21: 721-728 (Pubitemid 43372921)
19. Schwab SJ. Hemodialysis vascular access: the Achilles' heel remains. Kidney Int 2007; 72: 665-666 (Pubitemid 47373797)
20. Wijnen E, Planken N, Keuter X, et al. Impact of a quality improvement programme based on vascular access flow monitoring on costs access occlusion and access failure. Nephrol Dial Transplant 2006; 21: 3514-3519 (Pubitemid 44817102)
21. van Loon M, van der Mark MW, Beukers N, et al. Implementation of a vascular access quality programme improves vascular access care. Nephrol Dial Transplant 2007; 22: 1628-1632 (Pubitemid 47073761)
22. Lipari G, Tessitore N, Poli A, et al. Outcomes of surgical revision of stenosed and thrombosed forearm arteriovenous fistulae for haemo-dialysis. Nephrol Dial Transplant 2007; 22: 2605-2612 (Pubitemid 47365527)